Thursday’s Market Focus

Stock futures are mixed Thursday before the long holiday weekend in the U.S. and after the previous day’s sell-off.
Futures on the Dow Jones industrial average rose 1 point to 11,212, Nasdaq futures fell 6.00 to 1,819, while Standard & Poor’s 500 futures rose 1.10 to 1,263.90.
The Dow fell 166.75, or 1.46%, to 11,215.51, the lowest close since August 2006. The S&P 500 index fell 23.39, or 1.82%, to 1,261.52, while the technology-laden Nasdaq composite index fell 53.51, or 2.32%, to 2,251.46. The yield on the benchmark 10-year Treasury note fell to 3.96% from 4.01% late Tuesday. Crude oil hit a record $144.32 a barrel in after-hours trading after reaching a record settlement of $143.57, an advance of $2.60 on the New York Mercantile Exchange.
ECONOMIC DATA:
- Non-farm payrolls for June, 8:30 a.m. ET, -50,000 estimate
- Unemployment rate for June, 8:30 a.m. ET, 5.5% estimate
- Initial jobless claims, 8:30 a.m. ET, 385,000 estimate
- Institute for Supply Management non-manufacturing index for June, 10 a.m. ET, 50.7 estimate
AFTER-HOURS ACTION:
Nvidia Corp. late Wednesday cut its second-quarter revenue outlook to between $875 million and $950 million and said it expects to post a one-time charge of $150 million to $200 million for the quarter. The company said global end-market weakness, price adjustments for GPU products and a delayed ramp in its next MCP lay behind the lower outlook.
The FDA approved Abbott Laboratories’s Xience V drug-coated stent for coronary disease, the Abbott Park, Ill.-based health-care company said. The stent will be launched in the U.S. immediately. Separately, Boston Scientific Corp. said the approval cleared the way for the immediate U.S. launch of its Promus stent, which is already available in some overseas markets.
American Airlines parent company AMR Corp. said it expects to record a non-cash impairment charge of about $1.1 billion to $1.2 billion in the second quarter, related to the company’s capacity reduction plans.

Markets-hub.com